Onesource Specialty Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 11.44 Cr
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 450.59 Cr
- Satisfied Charges ₹ 1,250.24 Cr
- Revenue Growth 285.00%
- Profit Growth 51.15%
- Ebitda 60.89%
- Net Worth -49.44%
- Total Assets -34.85%
About Onesource Specialty Pharma
Onesource Specialty Pharma Limited (OSPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 12 June 2007 and has a history of 17 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Inbiopro Solutions Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 11.44 Cr.
The company currently has active open charges totaling ₹450.59 Cr. The company has closed loans amounting to ₹1,250.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Onesource Specialty Pharma Limited India are Anurag Bhagania as CFO and Allada Trisha as Company Secretary. Rajashri Ojha, Mahadevan Narayanamoni, Rashmi Barbhaiya, and Five other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L74140MH2007PLC432497
- Company No.
043095
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2007
- Date of AGM
23 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Chemicals
Onesource Specialty Pharma Limited
Explore comprehensive data for Onesource Specialty Pharma Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Onesource Specialty Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharma  | Managing Director | 01-Mar-2024 | Current |
| Anurag Bhagania | CFO | 01-Aug-2024 | Current |
| Allada Trisha | Company Secretary | 20-Apr-2023 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahadevan Narayanamoni | Director | 26-Mar-2021 | Current |
| Rajashri Ojha | Director | 04-May-2023 | Current |
Rashmi Barbhaiya  | Director | 17-May-2024 | Current |
| Bhushan Bopardikar | Director | 14-Aug-2023 | Current |
| Bharat Shah | Director | 26-Jul-2024 | Current |
| Gopakumar Nair | Director | 04-May-2023 | Current |
Financial Performance of Onesource Specialty Pharma.
Onesource Specialty Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 285% increase. The company also saw a substantial improvement in profitability, with a 51.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 49.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onesource Specialty Pharma?
In 2024, Onesource Specialty Pharma had a promoter holding of 30.29% and a public holding of 69.71%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raaj Gprac Private LimitedRajashri Ojha is a mutual person
Credila Financial Services LimitedBharat Shah is a mutual person
Exide Industries LimitedBharat Shah is a mutual person
Rhea Healthcare Private LimitedBhushan Bopardikar is a mutual person
Fermenta Biotech LimitedRajashri Ojha is a mutual person
Quality Care India LimitedMahadevan Narayanamoni is a mutual person
Charges (Loans)
Open Charges
₹450.59 Cr
Satisfied Charges
₹1,250.24 Cr
Charges Breakdown by Lending Institutions
- Others : 231.02 Cr
- Idbi Trusteeship Services Limited : 219.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2024 | Others | ₹50.00 Cr | Open |
| 27 Feb 2024 | Others | ₹150.00 Cr | Open |
| 25 Jan 2024 | Others | ₹0.20 M | Open |
| 21 Mar 2022 | Others | ₹20.00 Cr | Open |
| 13 May 2021 | Idbi Trusteeship Services Limited | ₹200.00 Cr | Open |
How Many Employees Work at Onesource Specialty Pharma?
Onesource Specialty Pharma has a workforce of 556 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onesource Specialty Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onesource Specialty Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Onesource Specialty Pharma
Recent activity within the organization
- Charges
A charge registered on 22 Apr 2024 via Charge ID 100928814 with Others was fully satisfied on 17 Dec 2024.
- Charges
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 100991824 was registered on 26 Sep 2024.
- Annual General Meeting
Onesource Specialty Pharma Limited last Annual general meeting of members was held on 23 Aug 2024 as per latest MCA records.
- Director Appointment
Anurag Bhagania was appointed as a Cfo was appointed as a Cfo on 01 Aug 2024 & has been associated with this company since 9 months 9 days .
- Director Appointment
Bharat Dhirajlal Shah was appointed as a Director was appointed as a Director on 26 Jul 2024 & has been associated with this company since 9 months 15 days .
- Director Appointment
Rashmi Harshadrai Barbhaiya was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 11 months 24 days .
Recent News, Updates & Announcement
Syngene to acquire multi-modal facility from Stelis Biopharma.To add 20,000 litres of installed biologics drug substance manufacturing capacity Syngene announced the acquisition of Unit 3 biologics manufacturing facility in Bengaluru, from Stelis Biopharma Limit.
- Strides Pharma Boosts Investment in Stelis Biopharma, Aims to Dominate Biopharmaceutical Market.
Strides Pharma Science invests more money in Stelis Biopharma to take control. They already put in $35 million for 43% ownership. Now, they'll add up to $40 million in 2 years to become a big player in biopharmaceuticals and get back into sterile injectables. Stelis will break even in 18 months with help from other partners. Stelis has a research facility in Bengaluru and makes biosimilars. Strides Pharma shares went up 0.18%..
- Strides board approves USD 15 mn investment in Stelis Biopharma.
The company's board has approved participation in the Series B fundraiser of Stelis Biopharma with a commitment of USD 15 million, Strides Pharma Science said in a regulatory filing. .
Frequently asked questions
What is the Incorporation or founding date of Onesource Specialty Pharma Limited?
Onesource Specialty Pharma Limited was incorporated on 12 Jun 2007.
What is authorized share capital and paid-up capital of Onesource Specialty Pharma Limited?
The authorized share capital of Onesource Specialty Pharma Limited is ₹ 15.00 Cr and paid-up capital is ₹ 11.44 Cr.
Who are the current board members & directors of Onesource Specialty Pharma Limited?
Currently 10 directors are associated with Onesource Specialty Pharma Limited.
- Rajashri Santosh Kumar Ojha
- Mahadevan Narayanamoni
- Anurag Bhagania
- Allada Trisha
- Rashmi Harshadrai Barbhaiya
- Neeraj Sharma
- Bhushan Sudhir Bopardikar
- Bharat Dhirajlal Shah
- Gopakumar Gopalan Nair
- Arun Kumar Pillai
What is the registered address of Onesource Specialty Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Onesource Specialty Pharma Limited is 201 Devavrata Sector 17 Vashi, Navi Mumbai India, Thane, Maharashtra, 400703.
What is the corporate identification number (CIN) and company number of Onesource Specialty Pharma Limited?
The corporate identification number (CIN) of Onesource Specialty Pharma Limited is L74140MH2007PLC432497 and the company number is 043095 as per Ministry of Corporate Affairs (MCA).
What is the official website of Onesource Specialty Pharma Limited?
The Official website of Onesource Specialty Pharma Limited is https://www.stelis.com
What has been the recent revenue trend for Onesource Specialty Pharma Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Onesource Specialty Pharma Limited has risen by 285.00%.
How many employees does Onesource Specialty Pharma Limited currently have?
As Per 2024 financial reports, 556 employees are currently employed by Onesource Specialty Pharma Limited.
What change has been observed in the net worth of Onesource Specialty Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Onesource Specialty Pharma Limited has experienced an downturn of -49.44%.
What are the total open charges for Onesource Specialty Pharma Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Onesource Specialty Pharma Limited amount to ₹ 450.59 Cr.
When was the last Balance Sheet of Onesource Specialty Pharma Limited filed with the ROC?
The most recent Balance Sheet for Onesource Specialty Pharma Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Sohang ChatterjeeWholetime Director
Mohana PillaiDirector
Mahendran BalachandranNominee Director
Ankur ThadaniDirector
Anand IyerDirector
Aditya PuriDirectorDV
Deepak VaidyaDirectorVI
Venkataraman IyerDirector
Similar Companies Based on Pharmaceuticals
Kandla Agro & Chemicals Private Limited Kachchh, Gujarat, India
Jodas Expoim Private Limited Medak, Telangana, India
Ivl Dhunseri Petrochem Industries Private Limited Kolkata, West Bengal, India
Sbl Energy Limited Raipur, Chattisgarh, India
Balaji Speciality Chemicals Limited Solapur, Maharashtra, India
Special Blasts Limited Raipur, Chattisgarh, India
Akums Drugs And Pharmaceuticals Limited Delhi, India